Nīderlande - holandiešu - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

zoetis b.v. - geinactiveerd rundervirusdiarreevirus; levend respiratoir rundersyncitisvirus; levend runderparainfluenza-3-virus - lyofilisaat voor suspensie voor injectie - live and inactivated viral vaccines - runderen

Eiropas Savienība - holandiešu - EMA (European Medicines Agency)

intervet international b.v. - cel-geassocieerde live recombinant turkije herpesvirus (stam hvp360), de uiting van de fusie-eiwit van nd-virus en de vp2 eiwit van ibd virus - aviaire herpes virus (marek ' s disease) + aviaire infectieuze bursitis disease virus (gumboro ziekte) + newcastle disease virus/paramyxovirus - chicken; embryonated chicken eggs - for active immunisation of one-day-old chicks or 18-19-day-old embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to prevent mortality and to reduce clinical signs and lesions caused by infectious bursal disease (ibd) virus,to reduce mortality, clinical signs and lesions caused by marek’s disease (md) virus.

Beļģija - holandiešu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium - levend kattencalicivirus rp = 1,26/dose; levend, geattenueerd, kattenherpesvirus 1 rp = 1,39/dose; geïnactiveerd, chlamydophila felis rp = 1,69/dose; levend, geattenueerd, kattenpanleukopenievirus rp = 8,50/dose - suspensie voor injectie - geïnactiveerd kattenrhinotracheïtisvirus; chlamydophila feline (= chlamydia psittaci); levend kattenpanleukopenievirus; levend kattencalicivirus - feline panleucopenia virus / parvovirus + feline rhinotracheitis virus + feline calicivirus + feline infectious leukaemia virus + chlamydia - kat

Eiropas Savienība - holandiešu - EMA (European Medicines Agency)

intervet international b.v. - cell-associated live recombinant turkey herpesvirus (strain hvt/ndv/ilt) expressing the fusion protein of newcastle disease virus and the glycoproteins gd and gi of infectious laryngotracheitis virus - immunologicals voor aves - embryonated chicken eggs; chicken - for active immunisation of one-day-old chicks or embryonated chicken eggs:to reduce mortality and clinical signs caused by newcastle disease (nd) virus,to reduce mortality, clinical signs and lesions caused by avian infectious laryngotracheitis (ilt) virus and marek’s disease (md) virus.

Eiropas Savienība - holandiešu - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologicals voor aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).

Eiropas Savienība - holandiešu - EMA (European Medicines Agency)

ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - kip - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Beļģija - holandiešu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

intervet international - geïnactiveerd boviene herpesvirus type 1 (bhv1) 60 elisa units ind. 6,1-11,1 log2 vnu/dose - suspensie voor injectie - bovine viral diarrhea (bvd)

Eiropas Savienība - holandiešu - EMA (European Medicines Agency)

merck sharp & dohme b.v.  - pneumococcal polysaccharide conjugate vaccine (adsorbed) - pneumokokkeninfecties - pneumococcus, purified polysaccharides antigen conjugated - vaxneuvance is indicated for active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by streptococcus pneumoniae in infants, children and adolescents from 6 weeks to less than 18 years of age. vaxneuvance is indicated for active immunisation for the prevention of invasive disease and pneumonia caused by streptococcus pneumoniae in individuals 18 years of age and older. zie hoofdstuk 4. 4 en 5. 1 voor informatie over bescherming tegen specifieke pneumokokken-serotypen. the use of vaxneuvance should be in accordance with official recommendations.

Nīderlande - holandiešu - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

intervet nederland b.v. - !!zie spc - neusspray, suspensie - bovine respiratory syncytial virus vaccine + bovine parainfluenza virus vaccine - runderen

Eiropas Savienība - holandiešu - EMA (European Medicines Agency)

bavarian nordic a/s - vibrio cholerae, stam cvd-103-hgr, live - cholera - vaccins - vaxchora is indicated for active immunisation against disease caused by vibrio cholerae serogroup o1 in adults and children aged 2 years and older. dit vaccin moet worden gebruikt in overeenstemming met de officiële aanbevelingen.